MedPage Today

FDA Approves Nalmefene Auto-Injector for Opioid Overdose

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...
FierceBiotech

Emergent launches in-licensed military-grade autoinjector outside the U.S., aims for FDA approval

Emergent BioSolutions ($EBS) has launched a military-grade intramuscular auto-injector device for self-administered antidotes or other chemical threat treatments. For ...
Business Insider

AMAG Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) accepted the supplemental new drug ...
Medscape

EMA Takes Steps to Improve Adrenaline Auto-Injector Use

The European Medicines Agency (EMA) has recommended several measures to better ensure appropriate patient and carer use of adrenaline auto-injectors for severe allergic reactions. The move is prompted ...
GEN

EU Approves Biogen Idec’s Avonex Intramuscular Autoinjector Product for MS

Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...